These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35691647)

  • 1. Epidemiological association of cannabinoid- and drug- exposures and sociodemographic factors with limb reduction defects across USA 1989-2016: A geotemporospatial study.
    Reece AS; Hulse GK
    Spat Spatiotemporal Epidemiol; 2022 Jun; 41():100480. PubMed ID: 35691647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic, Ethnocultural, Substance- and Cannabinoid-Related Epidemiology of Down Syndrome USA 1986-2016: Combined Geotemporospatial and Causal Inference Investigation.
    Reece AS; Hulse GK
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015.
    Reece AS; Hulse GK
    BMC Pediatr; 2022 Jan; 22(1):47. PubMed ID: 35042455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary epidemiology of rising atrial septal defect trends across USA 1991-2016: a combined ecological geospatiotemporal and causal inferential study.
    Reece AS; Hulse GK
    BMC Pediatr; 2020 Nov; 20(1):539. PubMed ID: 33250054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis.
    Reece AS; Hulse GK
    BMC Public Health; 2020 Nov; 20(1):1655. PubMed ID: 33148213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates.
    Reece AS; Hulse GK
    BMC Cancer; 2021 Feb; 21(1):197. PubMed ID: 33632159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State Trends of Cannabis Liberalization as a Causal Driver of Increasing Testicular Cancer Rates across the USA.
    Reece AS; Hulse GK
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study.
    Reece AS; Hulse GK
    BMC Cancer; 2021 Sep; 21(1):984. PubMed ID: 34479489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions.
    Reece AS; Hulse GK
    Arch Public Health; 2022 Mar; 80(1):100. PubMed ID: 35354495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis.
    Reece AS; Hulse GK
    Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):699-717. PubMed ID: 35779123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers.
    Reece AS; Hulse GK
    Arch Public Health; 2022 Mar; 80(1):101. PubMed ID: 35354499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis.
    Reece AS; Hulse GK
    Arch Public Health; 2022 Mar; 80(1):99. PubMed ID: 35354487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal inference multiple imputation investigation of the impact of cannabinoids and other substances on ethnic differentials in US testicular cancer incidence.
    Reece AS; Hulse GK
    BMC Pharmacol Toxicol; 2021 Jul; 22(1):40. PubMed ID: 34246312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends.
    Reece AS; Hulse GK
    Clin Pediatr (Phila); 2019 Sep; 58(10):1085-1123. PubMed ID: 31288542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis- and Substance-Related Epidemiological Patterns of Chromosomal Congenital Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.
    Reece AS; Hulse GK
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.
    Reece AS; Hulse GK
    Environ Epigenet; 2022; 8(1):dvac006. PubMed ID: 35386387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cannabis on congenital limb anomalies in 14 European nations: A geospatiotemporal and causal inferential study.
    Reece AS; Hulse GK
    Environ Epigenet; 2022; 8(1):dvac016. PubMed ID: 35966826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Epidemiological Patterns of Cannabis- and Substance-Related Body Wall Congenital Anomalies: Geospatiotemporal and Causal Inferential Study.
    Reece AS; Hulse GK
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use.
    Koch CD; Xu L; Curtis SA; Roberts JD; Bunch DR; El-Khoury JM
    Clin Chim Acta; 2020 Nov; 510():515-521. PubMed ID: 32795544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of recreational cannabinoid legalization on utilization in a pregnant population.
    Torres J; Miller C; Apostol M; Gross J; Maxwell JR
    Front Public Health; 2024; 12():1278834. PubMed ID: 38444440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.